Author: Max Eisenberg

The case of United States et al. ex rel. Schutte et al. v. SuperValu Inc. et al, 598 U.S. 739 (2023), is not just a story of pharmacy overcharging; it is the most significant Supreme Court ruling on the False Claims Act (FCA) in a generation. The Core Dispute: What is “Usual and Customary”? The...

In the complex machinery of the American healthcare system, trust is the primary lubricant. We trust that when a doctor writes a prescription, it is necessary. We trust that when a pharmacy bills the government, it has actually provided a service. However, a landmark whistleblower case settled in late 2024 (and finalized for public record...

On January 29, 2026, the Department of Justice (DOJ) Antitrust Division did something it has never done in its decades-long history: it cut a check for $1 million to an individual whistleblower. This payment wasn’t just a reward for “doing the right thing.” It was the culmination of a high-stakes investigation into EBLOCK Corporation, an...